213 related articles for article (PubMed ID: 11344835)
1. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease.
Zidan J; Robenstein W; Abzah A; Taman S
Isr Med Assoc J; 2001 Apr; 3(4):251-3. PubMed ID: 11344835
[TBL] [Abstract][Full Text] [Related]
2. Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma.
Brambilla L; Miedico A; Ferrucci S; Romanelli A; Brambati M; Vinci M; Tedeschi L; Boneschi V
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1090-4. PubMed ID: 16987264
[TBL] [Abstract][Full Text] [Related]
3. Raynaud's phenomenon and digital gangrene as a consequence of treatment for Kaposi's sarcoma.
Hladunewich M; Sawka C; Fam A; Franssen E
J Rheumatol; 1997 Dec; 24(12):2371-5. PubMed ID: 9415644
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of disseminated cutaneous classic Kaposi's sarcoma with vinblastine.
Turk HM; Buyukberber S; Camci C; Inaloz HS; Sari I; Kirtak N; Uner A
J Dermatol; 2002 Oct; 29(10):657-60. PubMed ID: 12432999
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the treatment of Kaposi's sarcoma with vinblastine in Togo: a study of 23 cases].
Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Balaka A; Pitché P; Tchangaï-Walla K
Bull Soc Pathol Exot; 2011 Dec; 104(5):339-41. PubMed ID: 21359830
[TBL] [Abstract][Full Text] [Related]
7. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
[TBL] [Abstract][Full Text] [Related]
8. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
9. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
[TBL] [Abstract][Full Text] [Related]
10. Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. The Military Medical Consortium for Applied Retroviral Research.
Smith KJ; Konzelman JL; Lombardo FA; Skelton HG; Holland TT; Yeager J; Wagner KF; Oster CN; Chung R
Arch Dermatol; 1992 Oct; 128(10):1365-70. PubMed ID: 1417025
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Kaposi's sarcoma in acquired immunodeficiency syndrome with an alternating vincristine-vinblastine regimen.
Kaplan L; Abrams D; Volberding P
Cancer Treat Rep; 1986 Sep; 70(9):1121-2. PubMed ID: 3742492
[TBL] [Abstract][Full Text] [Related]
12. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients.
Brambilla L; Bellinvia M; Tourlaki A; Scoppio B; Gaiani F; Boneschi V
Br J Dermatol; 2010 Apr; 162(4):854-9. PubMed ID: 19995366
[TBL] [Abstract][Full Text] [Related]
13. Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study.
Di Lorenzo G; Di Trolio R; Montesarchio V; Palmieri G; Nappa P; Delfino M; De Placido S; Dezube BJ
Cancer; 2008 Mar; 112(5):1147-52. PubMed ID: 18098221
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
Baskan EB; Tunali S; Adim SB; Kiyici M; Ali R
Int J Dermatol; 2006 Dec; 45(12):1441-3. PubMed ID: 17184252
[No Abstract] [Full Text] [Related]
15. [Kaposi's sarcoma].
Imamura A
Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
[TBL] [Abstract][Full Text] [Related]
16. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.
Laubenstein LJ; Krigel RL; Odajnyk CM; Hymes KB; Friedman-Kien A; Wernz JC; Muggia FM
J Clin Oncol; 1984 Oct; 2(10):1115-20. PubMed ID: 6208343
[TBL] [Abstract][Full Text] [Related]
17. Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS).
Tas F; Sen F; Keskin S; Kilic L
J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):789-92. PubMed ID: 22188463
[TBL] [Abstract][Full Text] [Related]
18. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study.
Nasti G; Errante D; Talamini R; Rizzardini G; Fasan M; Landonio G; Zeroli C; Chichino G; Nigra E; Vaccher E; Tirelli U
J Clin Oncol; 2000 Apr; 18(7):1550-7. PubMed ID: 10735904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]